Polymed Bets on New Plants, M&A for Global Expansion

Polymed is allocating INR 500 Cr for capital expenditure over the next two years to establish three new manufacturing plants in Haryana, Uttarakhand, and Rajasthan. 

Poly Medicure (Polymed), a prominent Indian manufacturer of medical devices and consumables, is preparing to expand its global presence.

The move aims to expand new production sites, strategic acquisitions, and a stronger focus on exports to markets such as the United States and Europe, according to Managing Director Himanshu Baid.

Based in Delhi-NCR, the company is currently debt-free and holds approximately INR 1,220 Cr in net cash, providing ample resources for its growth plans.

Polymed is allocating INR 500 Cr for capital expenditure over the next two years to establish three new manufacturing plants in Haryana, Uttarakhand, and Rajasthan.

These facilities will focus on expanding its renal product capacity and Contract Development and Manufacturing Organization (CDMO) offerings.

Construction is already underway at two locations, with work on the third site scheduled to commence soon.

“These facilities are designed to provide ‘sufficient capacity and capability for future, next 5-10 years,’” Baid noted, adding that such forward-looking moves are rare among Indian companies.

The company expects the plants to begin commercial operations by the end of calendar year 2026.

Stay tuned for more such updates on Digital Health News